Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-23-000067
Filing Date
2023-04-14
Accepted
2023-04-14 16:48:05
Documents
46
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmra-20230228.htm   iXBRL 10-Q 1119580
7 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 7923
8 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 8630
9 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4153
10 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 4221
  Complete submission text file 0001513162-23-000067.txt   4591395

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20230228.xsd EX-101.SCH 35093
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmra-20230228_cal.xml EX-101.CAL 32975
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20230228_def.xml EX-101.DEF 179230
5 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20230228_lab.xml EX-101.LAB 320687
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20230228_pre.xml EX-101.PRE 184031
40 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20230228_htm.xml XML 619711
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 23821782
SIC: 2835 In Vitro & In Vivo Diagnostic Substances